--- title: 'Senior Marketing Manager, Skeletal Dysplasia at BridgeBio Pharma' canonical: 'https://feeny.ai/job/senior-marketing-manager-skeletal-dysplasia-bridgebio-pharma-san-francisco-sdpr3bac78fx' type: 'job' last_seen: '2026-10-28' --- # Senior Marketing Manager, Skeletal Dysplasia at BridgeBio Pharma - **Company:** BridgeBio Pharma - **Location:** San Francisco, CA / Palo Alto, CA - **Compensation:** $160k–$190k - **Work type:** hybrid - **Posted:** 2026-10-28 - **Last confirmed live:** 2026-10-28 - **Apply:** https://job-boards.greenhouse.io/bridgebio/jobs/5274117007 ## Job description Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech” approach, pooling projects and promising early-stage research from academia together under one financial umbrella to reduce risk and unleash innovation. This model allows science and small teams of experts to lead the way. We build bridges to groundbreaking advancements in rare disease, and develop life-changing medicines for patients with unmet needs as fast as humanly possible. Together we define white space, push boundaries, and empower people to solve problems. If you're someone who defies convention, join us and work alongside some of the most respected minds in the industry. Together, we'll ask "why not?" and help reengineer the future of biopharma. At BridgeBio, we value curiosity and experimentation—including the ethical & thoughtful use of AI to improve clarity, speed, and quality of work. ## What You'll Do The Senior Marketing Manager will provide dedicated execution support for the commercialization of infigratinib, currently under FDA review for the treatment of achondroplasia.  This person will partner closely with both the HCP and Patient/Community market leads. This role blends tactical rigor with hands-on execution, translating patient and HCP brand strategy into high-quality marketing programs delivered on time and on budget. This person will be a critical connective thread across the patient and HCP marketing workstreams, working closely with cross functional partners in Advocacy, Market Insights, Market Access, Regulatory, Medical Affairs, Sales, Legal and agency partners to keep integrated commercial plans moving. The ideal candidate is someone who has product launch experience and can absorb strategic direction and reliably turn it into finished, compliant, on-brand deliverables — comfortable structuring ambiguity and rolling up their sleeves to get things done. This position requires excellent project management, communication, and cross-functional collaboration skills. The Marketing Manager will report to the Sr. Director of Marketing. ## Responsibilities Tactical Planning & Alignment - Serve as the day-to-day execution lead for patient and HCP marketing tactics - Translate brand strategy and messaging direction from the Patient and HCP marketing leads into clear execution plans, briefs, and timelines - Manage the tactical plan calendar across both workstreams, ensuring dependencies are visible, conflicts are surfaced early, and deadlines are met - Work closely with agency partners to manage ongoing deliverables, track project status, and communicate timelines to all internal and external stakeholders Marketing Asset & Content Development - Support development of assets across both patient and HCP marketing, including patient education materials and programs as well as HCP-facing tools and sales aids across digital and print channels - Act as the primary execution lead for day-to-day tasks for HCP speaker bureau, congress support, patient webinars, email campaigns, core print collateral, and more - Support end-to-end execution by aligning stakeholders, coordinating logistics, managing timelines, and ensuring flawless delivery - For select projects, support the medical, legal, and regulatory (MLR) review process for promotional and non-promotional materials, ensuring accuracy and compliance - Collaborate on content adaptation for multiple audiences (patients, caregivers, physicians, and other HCPs), maintaining message consistency and scientific integrity - Maintain organized documentation of approved claims, messaging platforms, and material versioning for ongoing team reference Patient Ambassador Programming & Congress/Conference Support - Support execution of patient ambassador programming, coordinating logistics, content, and stakeholder alignment - Identify priority conferences and advocacy events and ensure conference-ready resources are prepared for field and team execution - Lead end-to-end marketing execution for select patient and HCP conferences/events, including logistics coordination, materials management, and cohesive on-site brand presence Measurement, Budgeting & Operational Excellence - Define and track KPIs tied to patient and HCP tactic objectives; compile dashboards and status updates for leadership - Manage budget tracking and vendor/agency coordination for assigned programs, flagging risks early and driving resolution - Coordinate with digital marketing to build out and maintain customer engagement channels (websites, email, CRM/Veeva content) for both audiences - Partner with commercial operations, sales, brand analytics, IT, and MCM to ensure smooth field and channel execution - Analyze performance data and field feedback to inform continuous improvement and process efficiencies as the brand scales toward and through launch Where You'll Work This is a hybrid role and requires in-office collaboration 3x per week in our San Francisco or Palo Alto Office. ## Who You Are - 5-7 years of experience in digital marketing, communications, or product marketing, ideally within biotech, pharma, or a related healthcare industry - Proven ability to balance strategic direction from senior stakeholders with hands-on, detail-oriented execution - Strong project management skills; experience coordinating multiple concurrent workstreams, timelines, and budgets - Experience managing the MLR/promotional review process - Launch experience in a competitive market - Strong cross-functional collaboration skills and ability to influence without direct authority - Comfortable operating in fast-paced, ambiguous environments and making decisions with incomplete information - Results-oriented, with emphasis on ROI and performance metrics - Excellent oral, written, and presentation skills; strong proficiency in PowerPoint and core business tools - Passionate about serving patients suffering from genetic diseases - Proven self-starter, able to work independently and as part of a team, while keeping multiple stakeholders aligned - High level of self-awareness and understanding of the importance of self-monitoring behavior for continuous improvement - True entrepreneurial spirit – BridgeBio was built to do things differently and address the needs of underserved populations, driven by science and unrelenting passion for patients - Ability to travel (~20%) is required - You have demonstrated curiosity and adaptability in adopting AI-powered tools and technologies ## Preferred - MBA or other advanced degree - Healthcare advertising agency experience - Exposure to competitive intelligence, analytics, and market research/insights - Rare disease experience preferred ## #LI-LN1 At BridgeBio, we strive to provide a market-competitive total rewards package, including base pay, an annual performance bonus, company equity, and generous health benefits. Below is the anticipated salary range for candidates for this role who will work in California. The final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. BridgeBio is a multi-state employer, and this salary range may not reflect positions based in other states. Salary $160,000—$190,000 USD As a global company, our comprehensive benefits may vary based on location.  We have high expectations for our team members. We make sure those working hard for patients are rewarded and cared for in return. For BridgeBio Full-Time U.S Based Roles: Financial & Rewards - Market-leading compensation - 401(k) with employer match - Employee Stock Purchase Program (ESPP) - Pre-tax commuter benefits (transit and parking) - Referral bonus for hired candidates - Subsidized lunch and parking on in-office days Health & Well-Being - 100% employer-paid medical, dental, and vision premiums for you and your dependents - Health Savings Account (HSA) with annual employer contributions, plus Flexible Spending Accounts (FSA) - Fertility & family-forming benefits - Expanded mental health support (therapy and coaching resources) - Hybrid work model with flexibility - Flexible, “take-what-you-need” paid time off and company-paid holidays - Comprehensive paid medical and parental leave to care for yourself and your family Skill Development & Career Paths: - People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility - We provide career pathing through regular feedback, continuous education and professional development programs via LinkedIn Learning, LifeLabs, & BetterUp Coaching - We celebrate strong performance with financial rewards, peer-to-peer recognition, and growth opportunities By applying, you acknowledge that BridgeBio will process your personal information as described in our [Global Candidate Privacy Notice](https://bridgebio.com/bridgebio-global-candidate-privacy-notice). ## About BridgeBio Pharma ## Company Overview - **One-liner**: BridgeBio Pharma develops transformative medicines for genetic conditions, using a decentralized hub-and-spoke model to accelerate drug development from early research to commercialization. - **Entity Type**: Public (Nasdaq: BBIO) - **Headquarters**: Palo Alto, California, USA (with hybrid offices in San Francisco, CA) - **Founded**: Not explicitly stated in provided sources; the company references “over the past 10 years” as of 2026, suggesting founding around 2015–2016. - **Founders**: Not publicly available from provided sources. ## Core Business - **Primary industry**: Biotechnology / Genetic disease therapeutics - **Target customers**: Patients living with genetic conditions, healthcare providers, payers, and academic research partners - **Mission**: “To develop transformative medicines for genetic conditions” and “bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations.” ## Products & Services BridgeBio’s pipeline includes both approved therapies and investigational candidates across dozens of indications. Key offerings: - **Acoramidis**: Approved for transthyretin amyloidosis (ATTR) – a first-in-class treatment with $8B+ peak year sales potential. - **Infigratinib**: Phase 3 completed for achondroplasia; published in the *New England Journal of Medicine* (2026). - **BBP-418**: Investigational for Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9). - **Encaleret**: Investigational for Autosomal Dominant Hypocalcemia Type 1 (ADH1). - **BBP-812**: Investigational for Canavan Disease. - **BridgeBio Oncology Therapeutics (BBOT)**: Subsidiary focused on RAS and PI3Kα-driven cancers. - **GondolaBio**: Subsidiary developing bioavailable small molecule inhibitors for oncology. - **Other programs**: Covering hypochondroplasia, chronic hypoparathyroidism, and more. The company has received **3 FDA approvals** and has over **70+ peer-reviewed publications**. ## Market Standing - **Valuation / Market Cap**: Not explicitly stated in provided data; as a public company, current market cap can be found on financial platforms (e.g., ~$8B based on peak sales potential, but not a direct valuation number). - **Key Metric**: **3 FDA-approved medicines**; **2000+ patients enrolled** in global clinical trials; **6 Phase 3 trials** conducted over the past 10 years. - **Notable Investors / Partners**: Not detailed in provided sources, but the company partners with leading academic institutions to advance early-stage research. - **Growth Signals**: Recent publication of Phase 3 PROPEL 3 trial results in NEJM (June 2026); expansion into oncology via BBOT and GondolaBio; 100% of pipeline is first-in-class or best-in-class; 48 unique disease indications targeted. ## Competitive Advantages - **Hub-and-spoke model**: Decentralized structure where autonomous affiliate teams (spokes) focus on specific conditions, while a central hub provides clinical, regulatory, and commercial expertise. This enables speed, scalability, and risk reduction. - **First-in-class / best-in-class focus**: 100% of pipeline aims to be first or best in class, targeting underserved genetic conditions with clear biological rationale. - **Speed and adaptability**: The model allows rapid pivoting to the most promising opportunities, reducing development timelines compared to traditional biotech. - **Strong scientific foundation**: Over 70 peer-reviewed papers and collaborations with top academic institutions. ## Strategic Focus - **Advance late-stage pipeline**: Prioritize Phase 3 programs (e.g., infigratinib for achondroplasia, acoramidis for ATTR) and seek additional FDA approvals. - **Expand into oncology**: Leverage subsidiaries BBOT and GondolaBio to address RAS/PI3Kα-driven cancers. - **Maintain urgency**: “Every minute counts” – continue to operate with speed and autonomy to bring treatments to patients faster. - **Build on commercial success**: Leverage existing approved products to fund further R&D and expand global reach. ## Why Work Here - **Award-winning culture**: Named **#1 Best Place to Work** by BioSpace (2026, small biotech category) with an **88% employee engagement score** in 2025. - **Flexible work model**: Hybrid policy with offices in San Francisco and Palo Alto, CA; “flexible working model” emphasized. - **Compensation and benefits**: Market-leading pay, comprehensive healthcare, and strong emphasis on growth and internal mobility. - **Impact-driven mission**: Work on transformative treatments for genetic conditions where patient need is urgent – “Impatient for Patients” is a core mantra. - **Values**: Put patients first, let science speak, think independently, speak up, and act with urgency. The culture is described as “high on standards, low on convention.” - **Growth opportunities**: 113 open jobs (as of mid-2026) across functions including clinical, regulatory, manufacturing, commercial, and corporate; talent community available for future roles. ## Sources 1. [bridgebio.com](https://bridgebio.com/) – Home page with pipeline overview and $8B peak sales potential 2. [bridgebio.com/about](https://bridgebio.com/about) – Company description, hub-and-spoke model, and key metrics 3. [bridgebio.com/careers](https://bridgebio.com/careers) – Careers page with awards, culture, and benefits 4. [investor.bridgebio.com](https://investor.bridgebio.com/overview/default.aspx) – Investor relations overview, latest news, and corporate presentation 5. [job-boards.greenhouse.io/bridgebio](http://job-boards.greenhouse.io/bridgebio) – Current job listings (113 roles) and departmental categories ## Other roles at BridgeBio Pharma - [Senior Field Medical Director, Strategic Operations](https://feeny.ai/job/senior-field-medical-director-strategic-operations-bridgebio-pharma-san-4150ptsdsp16) — San Francisco, CA - [BD&Ops Director / Sr. Director](https://feeny.ai/job/bd-ops-director-sr-director-bridgebio-pharma-palo-alto-ffv4vme42c72) — Palo Alto, CA - [Field Reimbursement Manager, Southwest - Skeletal Dysplasia](https://feeny.ai/job/field-reimbursement-manager-southwest-skeletal-dysplasia-bridgebio-pharma-fay16wzevn61) — United States - [Field Reimbursement Manager, Southeast - Skeletal Dysplasia,](https://feeny.ai/job/field-reimbursement-manager-southeast-skeletal-dysplasia-bridgebio-pharma-fxt0f3sdwdn4) — United States - [Field Reimbursement Manager, Midwest - Skeletal Dysplasia](https://feeny.ai/job/field-reimbursement-manager-midwest-skeletal-dysplasia-bridgebio-pharma-united-b7mx2yyg45rj) — United States - [Director, Field Reimbursement - East](https://feeny.ai/job/director-field-reimbursement-east-bridgebio-pharma-united-states-rbt720p8m8g3) — United States - [Senior Manager / Associate Director, Medical Information](https://feeny.ai/job/senior-manager-associate-director-medical-information-bridgebio-pharma-united-43ankxcabebt) — United States - [Director, Government Pricing & Contract Operations](https://feeny.ai/job/director-government-pricing-contract-operations-bridgebio-pharma-san-francisco-3drkp53atz53) — /san Francisco CA & Palo Alto, CA - [Senior Manager, Corporate Communications](https://feeny.ai/job/senior-manager-corporate-communications-bridgebio-pharma-palo-alto-95nq7sks6gtc) — Palo Alto, CA - [Director, Managed Markets - Regional - Northeast](https://feeny.ai/job/director-managed-markets-regional-northeast-bridgebio-pharma-united-states-dfmav26y6zg3) — United States